These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Pohanka M; Kanovský P; Bares M; Pulkrábek J; Rektor I Parkinsonism Relat Disord; 2005 Dec; 11(8):509-12. PubMed ID: 15994112 [TBL] [Abstract][Full Text] [Related]
7. [Pergolide: a useful agonist for the treatment of Parkinson disease]. Bonnet AM; Houeto JL Rev Neurol (Paris); 2002 Jul; 158(6-7):744-5. PubMed ID: 12486908 [TBL] [Abstract][Full Text] [Related]
8. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211 [TBL] [Abstract][Full Text] [Related]
9. Bipolar affective disorder and Parkinson's disease: a rare, insidious and often unrecognized association. Cannas A; Spissu A; Floris GL; Congia S; Saddi MV; Melis M; Mascia MM; Pinna F; Tuveri A; Solla P; Milia A; Giagheddu M; Tacconi P Neurol Sci; 2002 Sep; 23 Suppl 2():S67-8. PubMed ID: 12548347 [TBL] [Abstract][Full Text] [Related]
10. Pergolide-induced retroperitoneal fibrosis. Mondal BK; Suri S Int J Clin Pract; 2000; 54(6):403. PubMed ID: 11092116 [TBL] [Abstract][Full Text] [Related]
11. Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Fernandez HH; Durso R Mov Disord; 1998 May; 13(3):597-8. PubMed ID: 9613761 [No Abstract] [Full Text] [Related]
12. [Multiple latency test in a patient with episodes of sleep induced by pergolide]. Jiménez-Jiménez FJ; Velasco I; de Toledo M; Sayed Y; Zurdo J; Ortí-Pareja M Rev Neurol; 2002 Jun 16-30; 34(12):1140-1. PubMed ID: 12134281 [TBL] [Abstract][Full Text] [Related]
13. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory. Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401 [TBL] [Abstract][Full Text] [Related]
14. A six-month study of pergolide and levodopa in de novo Parkinson's disease patients. Kulisevsky J; López-Villegas D; García-Sánchez C; Barbanoj M; Gironell A; Pascual-Sedano B Clin Neuropharmacol; 1998; 21(6):358-62. PubMed ID: 9844794 [TBL] [Abstract][Full Text] [Related]
15. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Olanow CW; Fahn S; Muenter M; Klawans H; Hurtig H; Stern M; Shoulson I; Kurlan R; Grimes JD; Jankovic J Mov Disord; 1994 Jan; 9(1):40-7. PubMed ID: 8139604 [TBL] [Abstract][Full Text] [Related]
16. Pergolide and Parkinson's disease: new preparation. No clear benefit. Prescrire Int; 2000 Dec; 9(50):177-9. PubMed ID: 11475497 [TBL] [Abstract][Full Text] [Related]
17. Pergolide and lisuride in advanced Parkinson's disease. Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Goldstein M Adv Neurol; 1984; 40():503-7. PubMed ID: 6695627 [TBL] [Abstract][Full Text] [Related]
18. [Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use]. van Strater AC; Bax JJ; van Hilten JJ; Jukema JW Ned Tijdschr Geneeskd; 2005 Apr; 149(16):891-4. PubMed ID: 15868996 [TBL] [Abstract][Full Text] [Related]
19. Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease. Cannas A; Solla P; Floris G; Tacconi P; Fulgheri P; Congia S; Spissu A Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):138-40. PubMed ID: 16033704 [TBL] [Abstract][Full Text] [Related]
20. Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease. Dewey RB; Reimold SC; O'Suilleabhain PE Arch Neurol; 2007 Mar; 64(3):377-80. PubMed ID: 17353380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]